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The structure of a Staphylococcus aureus leucocidin component
(LukF-PV) reveals the fold of the water-soluble species of a
family of transmembrane pore-forming toxins 
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Background: Leucocidins and γ-hemolysins are bi-component toxins secreted
by Staphylococcus aureus. These toxins activate responses of specific cells
and form lethal transmembrane pores. Their leucotoxic and hemolytic activities
involve the sequential binding and the synergistic association of a class S and a
class F component, which form hetero-oligomeric complexes. The components
of each protein class are produced as non-associated, water-soluble proteins
that undergo conformational changes and oligomerization after recognition of
their cell targets.
Results: The crystal structure of the monomeric water-soluble form of the F
component of Panton–Valentine leucocidin (LukF-PV) has been solved by the
multiwavelength anomalous dispersion (MAD) method and refined at 2.0 Å
resolution. The core of this three-domain protein is similar to that of α-hemolysin,
but significant differences occur in regions that may be involved in the mechanism
of pore formation. The glycine-rich stem, which undergoes a major rearrangement
in this process, forms an additional domain in LukF-PV. The fold of this domain is
similar to that of the neurotoxins and cardiotoxins from snake venom.
Conclusions: The structure analysis and a multiple sequence alignment of all
toxic components, suggest that LukF-PV represents the fold of any water-soluble
secreted protein in this family of transmembrane pore-forming toxins. The
comparison of the structures of LukF-PV and α-hemolysin provides some insights
into the mechanism of transmembrane pore formation for the bi-component toxins,
which may diverge from that of the α-hemolysin heptamer.
Introduction
Leucocidins (Luk) and γ-hemolysins (Ηlg) are bi-com-
ponent toxins secreted by Staphylococcus intermedius and
Staphylococcus aureus, one of the most frequently isolated
pathogens found in hospitals [1–6]. These toxins target
polymorphonuclear cells, monocytes, macrophages and ery-
throcytes and comprise the family of staphylococcal bi-
component leucotoxins [3,7]. Their toxicity involves the
synergistic combination of a class S and a class F compo-
nent [1], two non-associated exoproteins. These proteins
undergo conformational changes and form oligomeric com-
plexes after recognition of their cell targets, a process
leading to transmembrane-pore formation [5,8] and, ulti-
mately, to cell death.
Several Luk and Hlg toxins have been isolated from various
S. aureus strains. The genes for most of these isolated
toxins have been cloned and sequenced [2–4,6,9–11], and
the corresponding proteins have been partitioned into the
class F and class S subtypes. Among these toxins, the
Panton–Valentine leucocidin (PVL) was the first to be
reported [12], purified and characterized [1]. PVL-produc-
ing strains are associated with primary cutaneous lesions,
particularly furuncles [13–15], and the PVL toxin was shown
to be highly active on human and rabbit polymorphonuclear
leucocytes [3,8]. This toxicity requires the interaction of
the S component of PVL (LukS-PV) with a membrane-
bound receptor on human polymorphonuclear neutrophils
(PMNs), with a KD of less than 1 nM [16], followed by the
binding of the F component of PVL (LukF-PV) [17,18]. It
has been shown by flow cytometry, spectrofluorimetry and
immunological studies that these sequential interactions at
the membrane surface induce several responses of the target
cells, and that pores, which are specific for the traffic of
monovalent cations, are formed [8,19–21]. Biochemical data
argued for a heterohexameric assembly of the bi-compo-
nent toxins. Ultracentrifugation of toxins solubilized from
erythrocyte membranes indicated a molecular weight in the
order of 200 kDa and electrophoretic separations showed
similar amounts of the F (MW 34 kDa) and S (MW 32 kDa)
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components [5]. Studies of the interaction of several bi-
component toxins with purely lipidic vesicles, indicated
that they form membrane-attached oligomers. The two
components of each toxin were present in equal amounts,
suggesting a molar ratio of 1:1 in the oligomer [22]. The
best fit of the statistical analysis of the kinetics of vesicle
permeabilization indicated that the pores formed by the bi-
component toxins were hexameric species [22].
Here, we report the three-dimensional X-ray structure of
the secreted, water-soluble form of LukF-PV at 2.0 Å reso-
lution. The multiwavelength anomalous dispersion (MAD)
method was used to solve the structure of this 301 amino
acid protein. The LukF-PV structure was compared with
that of α-hemolysin from S. aureus [23], another pore-
forming toxin [24], which has been described in its homo-
heptameric pore-forming state [25]. Our study shows the
conservation of the core domains between these two toxins
[26] and illustrates the fold of the stem domain prior to
membrane insertion. The study also yields insights into
some of the significant conformational changes pertaining
to the mechanism of assembly in this family of toxins.
Results and discussion
Overall structure
The three-dimensional structure of LukF-PV contains 22 
β strands (64.4%) and three short segments of either 310 or
α helices (5.3%). These secondary structure elements are
organized into three structural domains: the β sandwich,
the rim and the folded stem (Figure 1a). The β-sandwich
domain (residues 1–61, 80–102, 154–169, 219–249 and
268–301) is made of two six-stranded antiparallel β sheets
facing each other with an average angle of 30°. The rim
domain (residues 62–79, 170–218 and 250–267) forms an
antiparallel four-stranded open-face sandwich [27], topped
by a stretch of residues (182–218). The conformation of
this stretch may be described as two consecutive Ω loops
followed by all the helical segments found in LukF-PV.
The core of the protein, made of the β sandwich and rim
domains, is similar to that of the α-hemolysin protomer
(Protein Data Bank [PDB] code 7AHL) [23]. Superimposi-
tion of the two protein structures can be achieved using
either the β-sandwich or the rim domains: the root mean
square (rms) differences are 0.82 Å (for 116 Cα atoms)
and 0.89 Å (for 74 Cα atoms), respectively. However, the
respective orientations of the β-sandwich and rim domains
differ in the two toxins (Figure 1b), due to a rigid-body
displacement which can be described as a 10.7° rotation
followed by a 0.19 Å translation along the rotation axis. This
movement may be related to the large conformational
change in the stem region of the proteins that occurs during
the process of membrane insertion [28,29].
Sequence alignment of LukF-PV and α-hemolysin was per-
formed, based on the superimposition of their three-dimen-
sional structures. The alignment was then extended to all
class F proteins, which share around 70% identity, and
also to the class S proteins, which share 59–75% identity
among one another. Between them, these two protein
classes share 26–30% identity. The resulting multiple
sequence alignment (Figure 2) revealed several conserved
residues in α-hemolysin, class F and class S proteins. The
positions of these residues, and their contribution to the
protein fold, were analyzed using the LukF-PV three-
dimensional structure. All of these residues have an impor-
tant structural role and most could be associated into
two groups. The first group comprises 12 residues: Ile59,
Tyr82, Tyr99, Pro101, Tyr149, Leu153, Trp164, Leu216,
Phe221, Pro223, Phe225 and Tyr245. The sidechains of
these residues form a continuous hydrophobic patch
involving all the strands in the β-sandwich domain
(Figure 3a), except for the three N-terminal strands (S1,
S2 and S3) and the two C-terminal strands (SG and SH),
which are located on the same side of the β sandwich. The
strands S2, S3 and S4 are, nevertheless, held together by
hydrogen-bond interactions formed between the invari-
ant Arg247, located in strand SF, and the mainchain
oxygen atoms of residues 30 and 60 (which belong to the
β turn between strands S2 and S3 and to S4, respectively).
These features suggest conservation of the β-sandwich fold
in all proteins. The second group of invariant residues is
located at the bottom of the rim domain and comprises
eight residues: Phe76, Trp78, Met192, Phe193, Phe207,
Asp250, Tyr252 and Asn265. The sidechains of these
residues provide a number of hydrophobic contacts, and
polar interactions are exchanged between three buried
residues (Figure 3b). The amide sidechain of Asn265 is at
hydrogen-bonding distance from the nitrogen atom of the
indole ring of Trp78 and from the carboxylic group of
Asp250. The conservation of these residues and interac-
tions might be regarded as a folding determinant of the
rim domain. The formation of this core may be needed to
accommodate the significant sequence variations between
the class F and S proteins, which are prevalent in the two
Ω-loop regions of the rim domain (Figure 2).
Conformational changes between the initial monomeric
water-soluble and final pore-forming states
The X-ray structures of LukF-PV and the self-assembling
α-hemolysin homoheptamer illustrate the molecular species
at the first and last steps of pore formation, respectively.
Pore formation is commonly described as a four-step process
involving the water-soluble secreted form, the membrane-
bound monomer [30], an oligomeric pre-pore [31,32], and
finally, the transmembrane pore itself [25]. The stem region,
comprising residues 106–148, is also known as the glycine-
rich stem. In each protomer of the α-hemolysin heptamer,
the stem forms two 65 Å long antiparallel β strands, which
protrude from the protein core (Figure 1b) and constitute
one building unit of the membrane-spanning 14-stranded
β barrel [23]. In the water-soluble LukF-PV protein, the
stem region is folded as a third domain made of three
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antiparallel β strands (ST1, ST2 and ST3) linked by one β
turn and one right-handed cross-over connection (Figure 1).
The junction to the β-sandwich domain is provided by
two short antiparallel strands: SB (residues 103–105) and
SC (residues 149–153). The stem domain is packed onto
the β-sandwich core, excluding an area of 2750 Å2 from
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Figure 1
Structural domains in LukF-PV and 
α-hemolysin. (a) Stereoview Cα trace of 
LukF-PV. Every tenth Cα atom is indicated by
a black dot. The N and C termini, the
secondary structure elements and the three
domains are labeled. (b) Stereoview of 
LukF-PV (the β-sandwich, rim and stem
domains are shown in cyan, magenta and
orange, respectively) superimposed onto one
protomer of α-hemolysin in the heptameric
oligomer (black). The rotation axis and the
angular range describing the rigid-body
motion (see text) are depicted in red. (The
figure was produced using the program
MOLSCRIPT [52].)
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the solvent. At each side of the stem–β-sandwich inter-
face, two groups of invariant residues provide a set of
interactions, which suggests that the fold of the stem
domain should be similar in all monomeric water-soluble
α-hemolysin, class F and class S proteins (Figure 4). The
sidechain of Asp43, from strand S3 of the β-sandwich
domain, is located at hydrogen-bonding distance from both
the mainchain nitrogen atom of residue Gly119 and the
phenolic group of Tyr116 of the stem. These interactions
would be impaired by the Cβ atom of any amino acid at
position 120, and probably explains the invariance of Gly120
(Figure 2). At the other edge of this interface, hydrogen
bonds are exchanged between Thr151 Oγ1 and the side-
chain atoms of residues Tyr144 and Gln146 from the folded
stem (Figure 4).
Pore formation by PVL requires the unfolding of the
stem domain. The differences in solvent accessibility of
the residues of this domain, in its folded and α-hemolysin-
like extended conformation, were evaluated. This calcula-
tion indicated that the sidechains that will be oriented
towards the nonpolar part of the lipid bilayer are, in most
cases, involved in the stem–β-sandwich domain interface. A
search for structural homology with other protein structures
using the programs DALI [33] and DEJAVU [34] revealed
significant similarity, despite very weak sequence homol-
ogy, between the stem domain and two toxins isolated from
snake venom: erabutoxin A [35] (PDB code 5EBX) and
toxin-γ [36] (PDB code 1TGX). The molecular architecture
of these two toxins is known as the three-finger fold [37].
The three central β strands, and loops II and III of these
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Figure 2
Sequence alignment for Staphylococcus
aureus α-hemolysin (α-HL), S. aureus
leucocidins (LukF-PV, LukD, LukF′-PV, 
LukS-PV, LukE and LukM), Staphylococcus
intermedius leucocidins (LukF-I and LukS-I),
and S. aureus γ-hemolysins (HlgB-MRSA,
HlgB, HlgC-MRSA, HlgC and HlgA). The
names of the F and S components of the 
bi-component toxins are written in orange and
black, respectively. The alignment was based
on the structure superimposition of LukF-PV
and α-HL. Secondary structure elements of 
α-HL (blue) and LukF-PV (red) were assigned
using the program DSSP [53]: β strands are
shown as arrows and α helices as coils; TT
and TTT are used to mark a β turn and an 
α turn, respectively. Sequence homologies
are highlighted in red; sequence identities are
shown as white letters on a red background.
Invariant residues in the β sandwich, the rim
and the stem domains are indicated using
triangles with the same color code as in
Figure 1b. The sequence numbering in blue is
for α-HL and the numbering in red is for 
LukF-PV. (The figure was created using
ESPript [http://www.ipbs.fr/ESPript].)
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α-HL ADSDIN .KT TT I SN L TY .. G K T Q.. RVYSE G.ANKI G D G TTVKTGD V D KEN MHK VFYSFIDDKNHNKKLLVIRTKG IAG Y E
LukF-PV   ..AQHI .PV EK V DK A SD .. K I N G.. TKPNP D.TIST S K D ITLYKTT T S DKL ISQ LTFNFIKDKSYDKDTLILKAAG IYS Y K
HlgB-MRSA ..EGKI .PV VK V DK A AD .. K I N G.. VKPNP D.YDFT S K D VTLYKTT T S DKF ISQ LTFNFIKDKSYDKDTLVLKATG INS F N
HlgB      ..EGKI .PV VK V DK A AD .. K I N G.. ERPNP D.YDFT S K D VTLYKTT T S DKF ISQ LTFNFIKDKSYDKDTLVLKAAG INS Y K
LukD      ..AQNI .PK EK V DK T AT DN N I N G.. KNSNP D.YNYT R K D ITLYFTK T S DKL IFQ LTFNFIKDKSYDKDTLVLKAAG INS Y K
LukF’-PV  ..AQHI .PV EK V DK T AT DS K I N G.. TQPTS S.SINT S K D ITLYFTK T S DKL ISQ LTFNFIKDKSYDKDTLILKAAG IYS Y D
LukF-I    ..ANQI .PV EK V DK A AD .. N L N G.. KSPNP D.YIYT S K D ITLYKTT T S DNL ISQ LTFNFIKDKSYDKDTLVLKAAG INS Y N
LukS-PV   .....D .NI NI D .. E TS .. G N F KTT YNY.. NTDHIN E G C AEVVKRT D C DKW VTQ IQFDFVKDKKYNKDALILKMQG INS Y K
HlgC-MRSA .....A .DT DI K SD E KT .. G N F RTT YNY.. KTNHVN E G G IEIIKRT D S NKW VTQ IQFDFVKDTKYNKDALILKMQG ISS Y K
HlgC      .....A .DT DI K ND E KT .. G N F RTT YNY.. NTNHIN E G G VEIIKRT D S NKW VTQ IQFGFVKDKKYNKVALILKMQG ISS Y K
HlgA      .....E .KI DI Q .. Q IT .. A N F RTT SDL.. KYPYIN E G G AEIIKRT D S KRL ITQ IQFDFVKDKKYNKDALVVKMQG ISS Y K
LukE      .....A TNI NI D .. F ED SS G N F RTS SDVKG GYELTN E G G AEVIKRT T V KKW VTQ VQFDFVKDKKYNKDALIVKMQG INS F R
LukM      .....A TNA DI D .. E VS .. G N F RTT NDV.. QNRANT E G D AEVIKRT D S RKW VTQ VQFDFVKDKKYNKDALIIKMQG INS F K
LukS-I    .....A .TI EI E .. E .. SS G N F RTS TDVKG GYESTN E G G AQIIKRT D V RKW VTQ IQFDFVKDPKYNKDALIIKMQG IKS F K
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α-HL G A .. S Q P NEV Y I TK M G DTGK G ANVS V KS L W P AFKV LQL D AQISDY PRNS D EY STLTYGFNGNVT D IG LIG IGHTLKY QPDF
LukF-PV   Q Y .. S S D NDS A N EF Q I NGLS G ..KS K RS F W G KYNI INS S VNVVDY PKNQ E QV QTVGYSYGGDIN S GG NGS FSETINY QESY
HlgB-MRSA K Y .. A S Q NDS A N EF Q I NGLS L ..TA K RS L W G KYNV ISS S VNAVDY PKNQ E QV NTLGYTFGGDIS S GG NGN FSETINY QESY
HlgB      K Y .. A S Q NDS A N EF Q I NGLS L ..TA K RS I W G KYNV ISS S VNVVDY PKNQ E QV NTLGYTFGGDIS S GG NGN FSETINY QESY
LukD      Q Y FT G S E NDA A N EF Q I NGLS L KSFT K RS F W G KYNV VSS S VNVVDY PKNQ E QV QTLGYSYGGDIN S GG NGS FSETINY QESY
LukF’-PV  Q Y FT A F E KDS A N EF Q I NGLT L KSFT K RS F W G KYNV VSS S VNIVDY PKNQ E QV QTLGYSYGGDIN I GG NGS FSETINY QESY
LukF-I    S Y .. A S E KGA A N EF Q I KGLS L ..ES K RS F W G KYNV ISA S VNVVDY PKNQ E QV NTLGYSFGGDIS S GG NGS FSETINY QESY
LukS-PV   A R .. F G N P.N L I SV S S PSTG . ..FN N IK M W P QYNI LKT D VDLINY PKNK D NV QTLGYNIGGNFN G .G NGS YSKTISY QQNY
HlgC-MRSA A R .. F G N K.Y L I ST S . APSL . ..FN T VK M W P QYNI LKT D VSLINY PKNK E NV QTLGYNIGGNFQ S GG NGS YSKSISY QQNY
HlgC      S R .. F G N K.Y L I ST S . APSL . ..FN T VK M W P QYNI LKT D VSLINY PKNK E NV QTLGYNIGGNFQ S GG NGS YSKSISY QQNY
HlgA      R I .. F S K S.N L I SA S . APSI . ..FN N VK M W P QYNI LKT D VDLINY PKNK D DV QKLGYNIGGNFQ S GG SGS YSKTISY QKNY
LukE      R I FT F G K P.N I T IE D F SAPS G FNYF T VK L W P QYNI LTT D VSLINS TLPK K TT VGQTLGYNIGGN Q IG NGS TSKTISY QKSY
LukM      R V .. F G K Q.N L I TV G . VPSI . ..FN S VK M W P QYNI LTS D TSLINY PKNK E DV QTLGYNIGGKFQ S GG NGS YSKSIKY QKSY
LukS-I    R L .. F A N P.N L I SI S . APLL . ..FN T IK I W P QYNI LKT D VFLINY PKNK E DV QTLGYNVGGNFQ S GG KGE YSKKISY QKNY
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α-HL I . G FNNMVNQ P DR WNPV G Q KT..RNG MKAA . P S LT LESPTD KKV WKVI NWG Y DS Y N LFM S DN FLD NKAS L SSGFSPDFATV
LukF-PV   S F G AHKIMNN P GR YHST G E GS..RQS LNAG . Y V ST LDKRTN KKI WDVE GWG Y DS Y N MFL N QN FLE HKMP L RGNFNPEFIGV
HlgB-MRSA T Y G AHKIMN. P GR FHPT G E AG..RQS AYAG . Q L S. LSRNTN KNV WGVE GWG Y DS Y N LFL S QN FIA HQMP L RSNFNPEFLSV
HlgB      T Y G AHKIMNN P GR FHPT G E AG..RQS AYAG . Q L ST LSRNTN KNV WGVE GWG Y DS Y N LFL S QN FIA HQMP L RSNFNPEFLSV
LukD      T H G AHKIMNN P GR YDPT G E GGFTDKS SNAG . T L AT IDRKTN KSI WGVE GWG Y DS Y N LFL S QN FLP HQIP L RGNFNPEFISV
LukF’-PV  T H G AHKIMNN P GR SDSL G E GGFTRQS SNAN . T I AT IDRKTN KSI WGVE GWG Y DS Y N LFL S QN FLP HQMP L RGNFNPEFISV
LukF-I    T N G AHKIMNA P GR FHDL G E GG..RQS LNAG . T L AT IDKHTD KTI WGVE GWG Y DS Y N LFL K QN FLP RQMP L RGNFNPEFLSV
LukS-PV   E . Q ......A I SL MSGH P . GY..KPY QNP. Y D P VS VEHQNS KSV WGIK NSF T GK D N LFV S RD FVP NELP L HSGFNPSFIAT
HlgC-MRSA E . L ......A A ES KSAF S . GY..KPH KDP. Y D P VS VEQQNS KSV WGVK NSF T GQ D D LFV S RD FVP SELP L QSGFNPSFIAT
HlgC      E . L ......A A ES KSAF S . GY..KPH KDP. Y D P VS VEQQNS KSV WGVK NSF T GQ D D LFV S RD FVP SELP L QSGFNPSFIAT
HlgA      E . K ......A V PN VSAY Q . Q...DPT PAA. Y D P IT VESQNS KGG WGVK NSF T GQ D Y LFA G RD FVP NQLP L QSGFNPSFITT
LukE      E . K ......A V PD KFAH R . QSPNGPT SARF Y D P VS VDKQNS KSV WGVK NKF T GK D Y LFV G TE FAP NQLP L QSGFNPSFITT
LukM      E . K ......A V AG WSAY E . R...NTT GPNA Y D P IS VEQQSS KTI WGVK NSF I HR D L LFI R RD FVD NELP L TSGFNPSFIAT
LukS-I    E . R ......A N EN VSAY R . R...SPI PNA. F N P IS VAQQNS KNI WEVK NSF T GQ D H LFV G RD FVP DELP L QSGFNPSFIAT
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α-HL D ASK.Q D QLHWTST..NWK T TKDKWT R S RYK KE. ....... .......ITM RK QTNIDVIYERVRD Y G N D S E IDWE EMTN .
LukF-PV   K AA..K R TNFWNQL..HWI N YKDENR T T IYE NH. IDTQSKE NPMS...LSR QN KSKITVTYQREMD Y G N A H S VDWE TVKL K
HlgB-MRSA R RA..K L QIRWNGF..YWA A YKNFKT T K TYE NH. LDTKETE NK.....LSH QD KSKITVTYQREMD Y G N R F S IDWE KVKL N
HlgB      R GA..K L QIRWNGF..YWA A YKNFKT T K TYE NH. LDTKETE NK.....LSH QD KSKITVTYQREMD Y G N R F S IDWE KVKL N
LukD      K DT..K R TNQFTWNRSHWV N YKNQNT T T TYE NI. KLIGTDS ETNPGV.LSH LF KSKIKVTYQREMD Y G N V F S VDWQ LLKL K
LukF’-PV  K DV..K R ENFFTWNNLHWI Y IKNQKR T T IYE KH. VASQSSE .......LSH QK KSKIKVTYQREMD Y G N A H S IDWE TVKL .
LukF-I    K GA..K E TNYWNGF..HWM T YKNQNN T T FYE QH. IKTHSDE NPS....LSH PN TSKIKVTYQREMD Y G N A F S IDWD TVKL K
LukS-PV   . GSG.D V HATRRTTHY... . SYLEGS I K ..F YTV NWKTHEI VKGHN..VSH EK TSEFEITYGRNMD T G N R H A VNRN KYEV K
HlgC-MRSA . GSS.D V HAIKRSTHY... . SYLDGH V N ..F YTV NWKTHEI VKGQN..VSH EK TSEFEITYGRNMD T G N R H A VNRN KYEV K
HlgC      . GSS.D V HAIKRSTHY... . SYLDGH V N ..F YTV NWKTHEI VKGQN..VSH EK TSEFEITYGRNMD T G N R H A KNRN KYEV K
HlgA      . GKG.D A YAYVTRPR.... . ..LAVD K D ..F VTV NWKTHEV IKSITPKLSH EK KSEFEITYGRNMD T . . R H A KNRN KYEV K
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toxins (the conformation of which is constrained by four
disulfide bridges) encompass the fold of the stem in LukF-
PV (Figure 5). The possible functional significance of this
structural similarity with respect to protein–membrane
interactions remains to be documented for the S. aureus
toxins. However, this finding suggested that formation of a
disulfide bridge between residues 128 and 144 in LukF-PV,
which would be analogous to the link between Cys43 and
Cys54 in the snake venom toxins (Figure 5), may be envi-
sioned. Such an engineered S. aureus toxin, where the
unfolding process of the stem domain would not go to
completion, may help to clarify some of the early steps of
membrane pore formation.
The sequence alignment (Figure 2), and the structure
superimposition of LukF-PV and the α-hemolysin proto-
mer indicate the invariance, in both residue type and posi-
tion, of Pro101 and Tyr149 (LukF-PV numbering), the
two residues between which the very large conformational
change of the stem region occurs. These hinge points
interact with residues from the β-sandwich core. The
mainchain carbonyl oxygen atoms of residues Ala100 and
Pro101 form hydrogen-bond interactions to the mainchain
nitrogen atom of Ile226 from strand S6, and the nitrogen
atom of the indole ring of the invariant Trp164, respec-
tively. In addition to the van der Waals contacts estab-
lished by the aromatic ring, the phenolic hydroxyl group of
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Figure 3
Stereoview superimposition of the three-
dimensional structures of LukF-PV (thick lines
and black bonds) and α-hemolysin (thin lines
and open bonds). The sidechains of the
invariant residues forming the core of the
domains are shown with atoms in standard
colours. The superimposition of (a) the 
β-sandwich domains and (b) the rim domains.
(The figure was produced using the program
MOLSCRIPT [52].)
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Tyr149 is at hydrogen-bonding distance (2.6 Å) from the
mainchain oxygen atom of Gly79 and the hydroxyl group
of Ser217. These interactions may have an important role
in preserving the positions of Pro101 and Tyr149 during
the structural transition leading to the disruption of the
stem–β-sandwich domain interface and the unfolding of
the stem. The free energy associated with these events
might be provided by the protein monomer–membrane
interactions prior to oligomerization and pore formation [38].
Homo-oligomers, hetero-oligomers and protomer multiplicity
A significant structural difference was observed in the
N-terminal regions of LukF-PV and the α-hemolysin pro-
tomer (Figure 1b). The difference in conformation, and
the contribution of these 16 residues to protomer–proto-
mer associations may be relevant to the final oligomeric
state of these toxins.
The N-terminal region in LukF-PV, which is two residues
shorter in all class F proteins compared to α-hemolysin,
showed no sensitivity to proteolytic enzymes and consti-
tutes the outermost external, 12-residue long strand (S1) of
the β-sandwich domain (Figure 1a). In contrast, the N-ter-
minal latch (residues 1–16) in α-hemolysin has no defined
secondary structure. In the heptameric toxin, this region
forms numerous interactions with adjacent protomers which
contribute to the stability of the macromolecular assembly
[23]. These interactions seem essential as deletion of only
the two N-terminal residues abolishes the hemolytic activ-
ity of the toxin [30]. In the monomeric and soluble α-hemo-
lysin, this region was found sensitive to proteolysis and
assumed to be loosely organized [39].
In the process of α-hemolysin oligomerization, a cooperative
effect between a conformational change of the N-terminal
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Figure 4
Ribbon representation illustrating the interactions between invariant
residues (see text) that anchor the folded stem domain (orange) to the
β-sandwich domain (red). (The figure was produced using the program
MOLSCRIPT [52].)
Figure 5
Stereoview of the stem domain of LukF-PV
(deep blue) superimposed on the three-
dimensional structures of erabutoxin A from
Laticauda semifasciata (red) and toxin-γ from
Naja nigricollis (green); the root mean square
(rms) differences for 24 Cα atoms are 0.9 Å
and 1.8 Å, respectively. The four disulfide
bridges present in both snake venom toxins
are displayed with thick lines and the Cα
atoms of each cysteine residue are indicated
by colored dots. (The figure was produced
using the program MOLSCRIPT [52].)
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region and the transition from the soluble monomeric
form to the pore-forming heptameric structure  was pro-
posed [39]. The loose organization postulated for this
region, and the inspection of the superimposed LukF-PV
and α-hemolysin structures support this hypothesis. Accom-
modation of the 16 N-terminal residues, in the conforma-
tion they adopt in the pore-forming heptamer, seems
sterically incompatible with a folded stem according to the
LukF-PV structure (Figure 1b).
A similar oligomerization process for the bi-component
toxins would imply that the N-terminal strand S1 dissoci-
ates from its antiparallel strand S2. Assuming that this
transition occurs, the possibility that the F and S compo-
nents may form homo- or heteroheptameric pores similar
to that of α-hemolysin was examined. The α-hemolysin-
like pore-forming protomers of the F and S proteins were
generated with the reasonable assumption that the confor-
mation of the unfolded stem regions should be very
similar in all three proteins. The oligomers were modeled
by superimposition of the unfolded stem regions of the F
and S proteins onto each pair of strands of the 14-stranded
β-barrel pore. Examination of the protomer–protomer con-
tacts in these hypothetical heptamers showed that their
formation was unlikely without additional conformational
changes in the β-sandwich domain. A majority of seem-
ingly incompatible sidechain substitutions, from α-hemo-
lysin to the F and S proteins, occur for the residues involved
in the 29 tight hydrogen-bond interactions contributing to
the association of consecutive protomers in α-hemolysin.
On the other hand, assuming unfolding of the stem domain
but no dissociation of the N-terminal S1 strand from the
β sandwich was also incompatible with the formation of
heptameric oligomers of F and S proteins. Obvious steric
clashes occur between adjacent protomers, which arise from
the folded N-terminal strand. These modeling approaches
suggested that the structure of the pore in PVL may
diverge from the α-hemolysin heptamer, which would
agree with the proposal that the oligomeric bi-component
toxins contained equimolar proportions of class F and S
monomers in a hexameric assembly [5,22].
The transmembrane pore resulting from a hexameric
assembly would be a 12-stranded antiparallel β barrel, the
geometrical and topological characteristics of which have
been described [40,41]. In this barrel, the shear number
(S) equals the number of strands in the β sheet, a feature
that was also specific to the 14-stranded β barrel α-hemo-
lysin pore. The inner diameter of the pore (21 Å) is in
good agreement with the experimental data on γ-hemo-
lysin [5] and PVL [42], which indicated a functional
diameter of about 21–24 Å. The tilt of the strands to the
β barrel axis is 37°, in line with the average angle formed
by the β strands with the normal of the plane of the
membrane, which was estimated to be 36–38° for the bi-
component toxins in small unilamellar vesicles [22]. The
heterohexameric pore was constructed assuming unfolded
stem regions for the F and S proteins and without alter-
ing the position of strand S1. Each antiparallel β strand of
the stem was superimposed onto one pair of strands of
the 12-stranded β barrel, and the resulting positions of
the β-sandwich and rim domains in the mushroom-shaped
complex showed no bad contacts (Figure 6). One of the
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Figure 6
Molecular model of heterohexameric PVL assuming no unfolding of
strand S1 from the β-sandwich domain. The conformation of the stem
region was derived from that of the α-hemolysin protomer [23]. The
architecture of the pore was based on the topology of a 12-stranded
β barrel [41]. (a) View perpendicular to the sixfold axis. The LukF and
LukS subunits are shown in blue and yellow, respectively; the N
termini are shown in red. (b) View down the sixfold axis from the top
of the cap. (The figure was produced using the program
MOLSCRIPT [52].)
interprotomer interactions involved the folded N-termi-
nal strand and the model suggested that additional residues
at the N terminus should not impair oligomerization. We
therefore engineered a LukF-PV protein containing eight
additional residues (Gly-Pro-Leu-Gly-Ser-Pro-Glu-Phe) at
the N terminus and found no change in the toxicity of this
PVL on PMN cells compared to that of the native protein
(GP, unpublished data).
Leucotoxins composed of a given S component and
supplied with different class F proteins exhibit different
levels of toxicity on selected cell types [11], suggesting
either interaction of the F proteins with the membrane-
bound receptor of LukS-PV or incomplete pore formation
resulting from some mismatch between some F proteins,
the S protein and/or the membrane components. The pos-
sible mismatch between the F and S proteins could only
be addressed from the X-ray structure of LukF-PV. An
analysis of the sequence variation within the class F pro-
teins showed that they occur in regions located at the F–S
interface, and at the solvent-exposed region of the toxin.
The former location may be consistent with the different
levels of cytotoxicity observed with the various combina-
tions of S and F molecular species.
The protein monomer–membrane interactions are likely
to contribute to the drastic conformational transitions
leading to the disruption of the 2750 Å2 interface between
the folded stem and the β-sandwich domain, and to the
formation of significant protomer–protomer interfaces in
the oligomeric species [23]. These processes might be
influenced by the chemical content of the membrane,
which may provide some explanation for the recently pro-
posed polymorphism of the α-hemolysin toxin formed in
different membrane layers [43]. In the case of PVL, the
binding of LukS-PV to its high-affinity membrane-bound
receptor may also drive molecular events. The cooperative
effect in the transition from a folded stem to other species,
which in the case of the self-assembling α-hemolysin
could involve the conformational change of the N-termi-
nal region, may arise in PVL from protein–receptor binding
interactions. The structure of the soluble form of LukF-
PV should help in the design of engineered proteins for
further investigations of the binding and oligomerization
of these protein subunits in membranes.
Biological implications
Leucocidins, γ-hemolysins and α-hemolysin are exotoxins
produced by Staphylococcus aureus, a common pathogen in
hospitals. These toxins are secreted as water-soluble pro-
teins of about 33 kDa but form oligomeric species upon
binding to the cell membrane. This oligomerization leads
to pore formation and is commonly described as a four-
step process involving the water-soluble species, the mem-
brane-bound monomer, an oligomeric pre-pore and finally
the transmembrane pore.
Although α-hemolysin is a self-assembling toxin, leuco-
cidins and γ-hemolysins are bi-component toxins that
act through the sequential binding and synergistic asso-
ciation of a class S and a class F component to form
hetero-oligomeric complexes. X-ray structure determi-
nation of the pore-forming oligomer of α-hemolysin,
formed in deoxycholate micelles, revealed a heptameric
organization. In this mushroom-shaped structure, the
transmembrane pore appears as a 14-stranded antipar-
allel β barrel in which each protomer contributes two
65 Å long antiparallel strands. In this work, the X-ray
structure of the water-soluble form of the F component
of the Panton–Valentine leucocidin (LukF-PV), solved
by the multiwavelength anomalous dispersion (MAD)
method, illustrates the molecular species that undergoes
the conformational changes and oligomerization pro-
moted by  membrane association. The conservation of
the folding determinants of the protein, established on
the basis of a multiple sequence alignment of all toxic
components, suggests that the structure of LukF-PV
represents the fold of any water-soluble protein in this
family of toxins. The membrane-spanning region of the
toxin forms an additional domain in the monomeric
protein, tightly packed onto the protein core. The topol-
ogy of this domain is similar to that of erabutoxin A and
toxin-γ from snake venom.
Biochemical and biophysical studies argued for hexam-
eric assemblies of leucocidins and α-hemolysins, contain-
ing similar amounts of the F and S components. Modeling
attempts of heptameric and hexameric oligomers of
PVL, based on 14-stranded and 12-stranded antiparallel
β-barrel pores, respectively, were in favor of the hetero-
hexameric assembly of PVL.
Materials and methods
Purification of LukF-PV
The reference S. aureus ATCC49775 was grown in yeast extract
casaminoacid sodium pyruvate (YCP) medium [11] for 16 h at 37°C
with vigorous shaking. The proteins in the culture supernatant were
precipitated with ammonium sulfate. The pellet was solubilized in
30 mM sodium phosphate (pH 6.5) and then dialyzed against the
same buffer. Negatively charged proteins were discarded by two con-
secutive separations on SP fast flow and MonoS columns (Pharmacia,
Uppsala, Sweden) using fast protein liquid chromatography (FPLC) at
4°C with an NaCl gradient ranging from 0 to 700 mM. Protein frac-
tions (80–120 mM NaCl) were pooled and adjusted to 50 mM potas-
sium phosphate, 1.5 M (NH4)2SO4 (pH 7.0) for chromatography on an
alkyl-superose FPLC column (Pharmacia). Pure LukF-PV was eluted
from a linear (NH4)2SO4 gradient (1.5–0 M). The protein was stored at
0.6 mg/ml (OD280nm = 1.0) in 30 mM sodium phosphate, 200 mM
NaCl (pH 6.5).
Crystallization
Crystals of LukF-PV were obtained at 4°C by seeding microcrystals in
pre-equilibrated hanging drops containing the protein (20 mg/ml) in
200 mM Tris and MES buffer (pH 6.8–7.0), 21% PEG 4000 (W/V) and
7 mM cadmium chloride. The crystals belong to orthorhombic space
group P212121 with cell parameters a = 50.7 Å, b = 73.3 Å, c = 99.7 Å,
with one molecule per asymmetric unit.
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Data collection and phasing
A MAD experiment was performed on a single crystal soaked with
(NH4)2IrCl6. Soaking was performed in an X-ray capillary by adding the
iridium salt solubilized in the reservoir solution to the crystal in mother
liquor. The final concentration and soaking time were 2 mM and 16 h,
respectively. An equal volume of a cryoprotectant solution (20% glyc-
erol [w/v] in the solution used for heavy-atom soaking) was then added
for 1 h. The content of the capillary was transferred on a glass plate
and the crystal mounted in a cryo-loop and flash-cooled to 100K in a
stream of nitrogen gas. Care was taken to properly orient the crystal in
the cryo-loop in order to record the Bijvoet pairs on the same frame.
MAD diffraction data were collected at four wavelengths on X31 beam
line of the EMBL Hamburg Outstation at the Deutsches Elektronen-
Synchrotron (DESY, Germany). A fluorescence spectrum, recorded
with the frozen crystal prior to data collection, was used to select the
wavelengths in the iridium LIII absorption edge (λ2 = 1.1053 Å,
maximum of |f′ |), at the peak (λ3 = 1.1048 Å, maximum of f′′) and at two
remote wavelengths (λ1 = 1.1270 Å and λ4 = 0.8269 Å) (Figure 7).
Data were collected on an 18 cm MAR research image plate with
detector distance 180 mm, frame size 1° and approximately 4 min
exposure time. Reflection intensities were processed using the
program DENZO [44]. The CCP4 suite of programs [45] was then
used to merge and scale these intensities and to compute the struc-
ture-factor amplitudes (Table 1). For scaling and all subsequent steps,
the low-energy reference data set (λ1) was chosen as ‘native’ data set.
Three major heavy-atom sites were identified in dispersive difference
Patterson maps at 4.0 Å resolution. Heavy-atom refinement and MAD
phasing were conducted with SHARP [46] using all data between
24.4 and 2.0 Å (Table 2), which indicated four additional sites in the
anomalous residual map computed at λ3. The electron-density map
was improved by solvent flattening in SOLOMON [47] assuming a
solvent content of 48% in the unit cell.
Model building and crystallographic refinement
The modified 2.0 Å resolution electron-density map allowed tracing of
88% of the LukF-PV molecule, including 81% of sidechain atoms. The
structure was refined by the maximum-likelihood method as imple-
mented in REFMAC [48] including a bulk-solvent correction computed
in X-PLOR [49], followed by manual fitting into SIGMAA-weighted elec-
tron-density maps with TURBO-FRODO [50]. Reflections between 24.4
and 2.0 Å were used in the refinement, excluding a random set of data
(5%) for the calculation of the free R factor [51]. The final model com-
prises 2389 nonhydrogen atoms in LukF-PV, seven iridium species, one
cadmium ion, 168 water and 2 MES buffer molecules. The rms devi-
ations from ideal geometry were calculated: bond lengths, 0.012 Å;
angles, 2.3°; dihedrals, 27.7°. The crystallographic R value and Rfree
were 0.20 (for 19,969 reflections) and 0.24 (for 1080 reflections),
respectively. The average B factors are 15.3 Å2 for protein atoms
(14.2 Å2 and 16.3 Å2 for mainchains and sidechains, respectively),
50.9 Å2 for the iridium species, 39.1 Å2 for the cadmium ion and 31.5 Å2
and 19.8 Å2 for the MES buffer and water molecules, respectively.
Ser129 and the three consecutive glycine residues (Gly130–Gly132)
display the highest temperature factors in the structure and no clear
electron density could be assigned to Asn133, Gly134 and Ser135.
Flexibility of the polypeptide chain, rather than cleavage in this region,
should be invoked as sodium dodecylsulfate polyacrylamide gel elec-
trophoresis (SDS–PAGE) of dissolved crystals only revealed a single
protein band corresponding to the full-length protein.
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Table 1
Data collection statistics.
Wavelength Resolution (Å) Reflections Completeness (%) Rsym† Riso‡ Rano§
(Å) (outer shell)* measured/unique (outer shell)* (outer shell)*
Remote λ1 1.1270 24.4–2.0 96,992/21,089 85.0 0.060 – 0.037
(2.12–2.0) (88.0) (0.101)
Edge λ2 1.1053 24.4–2.0 92,737/21,121 85.1 0.071 0.042 0.048
(2.12–2.0) (89.8) (0.123)
Peak λ3 1.1048 24.4–2.0 80,455/21,495 86.7 0.064 0.040 0.056
(2.12–2.0) (89.7) (0.111)
Remote λ4 0.8269 24.4–2.0 74,044/20,710 83.3 0.063 0.051 0.050
(2.12–2.0) (89.8) (0.121)
*Values in parentheses are for the highest resolution shell. †Rsym = Σ Σ | <Ι> − Ii | / ΣΣ Ii. ‡Riso = Σ | FPH – FP | / Σ | FP |.
§Rano = Σ | < I+ > – < I– > | / Σ (< I+ > + < I– >).
Table 2
MAD phasing statistics.
Wavelength f′/f′′ *(e–) Ppiso † Ppano † RisoCullis† R anoCullis† FOM†
(Å) acentric/centric acentric/centric acentric/centric
Remote λ1 1.1270 –10.7/4.0 – 1.39 – 0.86 0.56/0.41
Edge λ2 1.1053 –22.0/8.5 1.84/1.18 2.06 0.57/0.59 0.72
Peak λ3 1.1060 –16.8/15.5 1.01/0.78 2.46 0.61/0.63 0.63
Remote λ4 0.8269 –3.8/10.2 1.29/0.97 1.81 0.71/0.75 0.76
*Values of anomalous scattering factors, as refined by SHARP [46], used for phasing. †Phasing statistics provided by the program SHARP [46];
FOM, figure of merit.
Accession numbers
The coordinates and structure factors are deposited in the Protein
Data Bank with accession code 1pvl, to become available at the time
of publication.
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Figure 7
The energy dependence of the anomalous scattering factors f′ and f′′
in the vicinity of the iridium LIII absorption edge, as derived from the
fluorescence spectrum. The energies corresponding to the four
working wavelengths are labeled: 2 (edge), 3 (peak), 1 and 4 (two
remote points).
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